Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic Value of Tissue Factor in Colorectal Cancer
NCT02304978Phase 1Completed
- Sponsor
- CHU de Lille
- Start
- Jun 2009
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by CHU de Lille. Primary endpoint: TNM primary colorectal tumor stage. Started Jun 2009; status: completed.
Beyond the preview
Go deeper on NCT02304978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304978.